= Emerging. More than 5 years before clinical availability. (26.62%)
= Expected to be clinically available in 1 to 4 years. (38.91%)
= Clinically available now. (34.47%)
MSACL 2020 US : Povilaitis

MSACL 2020 US Abstract

Topic: Microbiology

Podium Presentation in Room 4 on Thursday at 9:00 (Chair: Chris Cox)

Identification of Clinically Relevant Microbes with the MasSpec Pen

Sydney Povilaitis (Presenter)
University of Texas at Austin

Presenter Bio(s): Sydney C. Povilaitis received her B.A. in Chemistry from St. Olaf College in Northfield, Minnesota in 2018. Currently, she is a graduate student in Prof. Livia S. Eberlin’s lab at the University of Texas at Austin. Her research focuses on developing the MasSpec Pen for molecular differentiation of microbes and skin lesions.

Authors: Sydney C. Povilaitis (1), Ashish Chakraborty (1), Lindsey M. Kirkpatrick (2), Sarmistha B. Hauger (3) and Livia S. Eberlin (1)
(1) The University of Texas at Austin, Austin, TX, USA (2) Indiana University School of Medicine, Indianapolis, IN, USA (3) Dell Children’s Medical Center, Austin, TX, USA

Abstract

This abstract is currently under embargo.


Financial Disclosure

DescriptionY/NSource
GrantsyesThe Moore Foundation
Salaryno
Board Memberno
Stockno
Expensesno
IP Royaltyno

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no